We are live on ! Find out more
RBFC

Roman Butler Fullerton & Co Portfolio holdings

AUM $419M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-3.72%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
–
AUM
$157M
AUM Growth
-$22.8M
Cap. Flow
-$11.8M
Cap. Flow %
-7.51%
Top 10 Hldgs %
28.08%
Holding
185
New
10
Increased
91
Reduced
50
Closed
16

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.15M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$1.07M
3
MOH icon
Molina Healthcare
MOH
+$983K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$888K
5
LNG icon
Cheniere Energy
LNG
+$796K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.1M
2
UTHR icon
United Therapeutics
UTHR
+$1.57M
3
MSFT icon
Microsoft
MSFT
+$1.46M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.41M
5
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$971K

Sector Composition

Rank Sector Weight
1 Technology 16.56%
2 Healthcare 15.78%
3 Financials 8.85%
4 Consumer Staples 7.56%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$130B
$1.41M 0.9%
20,290
+96
+0.5% +$6.96K
LOW icon
27
Lowe's Companies
LOW
$124B
$1.4M 0.89%
7,135
+49
+0.7% +$9.54K
REGN icon
28
Regeneron Pharmaceuticals
REGN
$82.1B
$1.35M 0.86%
+1,826
New +$1.15M
IVV icon
29
iShares Core S&P 500 ETF
IVV
$902B
$1.34M 0.85%
3,731
-63
-2% -$25.2K
IGR
30
CBRE Global Real Estate Income Fund
IGR
$702M
$1.31M 0.83%
232,072
+27,499
+13% +$201K
DDOG icon
31
Datadog
DDOG
$88.6B
$1.25M 0.8%
15,177
– –
USMV icon
32
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$1.25M 0.79%
18,805
+31
+0.2% +$2.23K
ABT icon
33
Abbott
ABT
$190B
$1.24M 0.79%
12,206
+11
+0.1% +$1.17K
FANG icon
34
Diamondback Energy
FANG
$56.5B
$1.24M 0.79%
8,880
-4,788
-35% -$597K
DG icon
35
Dollar General
DG
$26.5B
$1.23M 0.78%
5,138
+46
+0.9% +$11.3K
NBIX icon
36
Neurocrine Biosciences
NBIX
$16.5B
$1.14M 0.72%
+10,559
New +$1.07M
AEE icon
37
Ameren
AEE
$29.8B
$1.11M 0.71%
14,246
+15
+0.1% +$1.37K
JPM icon
38
JPMorgan Chase
JPM
$962B
$1.1M 0.7%
10,799
+371
+4% +$42.6K
EOS
39
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$1.09M 0.69%
70,672
+9,132
+15% +$162K
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$13.5B
$1.09M 0.69%
12,381
+2,019
+19% +$180K
MOH icon
41
Molina Healthcare
MOH
$10.2B
$1.08M 0.68%
+3,054
New +$983K
CVS icon
42
CVS Health
CVS
$120B
$1.07M 0.68%
12,122
-62
-0.5% -$6.14K
DGRO icon
43
iShares Core Dividend Growth ETF
DGRO
$43.7B
$1.05M 0.67%
23,504
+402
+2% +$19.8K
MRK icon
44
Merck
MRK
$322B
$1.05M 0.67%
11,526
+46
+0.4% +$4.11K
VLO icon
45
Valero Energy
VLO
$93.3B
$1.05M 0.67%
9,560
-63
-0.7% -$6.93K
SPY icon
46
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$1.03M 0.65%
2,879
+2,237
+348% +$888K
EMR icon
47
Emerson Electric
EMR
$91.7B
$1M 0.64%
12,887
+3,009
+30% +$250K
SSUS icon
48
Day Hagan/Ned Davis Research Smart Sector ETF
SSUS
$584M
$985K 0.63%
34,117
-16,220
-32% -$515K
PEP icon
49
PepsiCo
PEP
$189B
$980K 0.62%
6,030
+13
+0.2% +$2.24K
PH icon
50
Parker-Hannifin
PH
$134B
$971K 0.62%
3,808
-66
-2% -$17.9K
1
2
3 4 5

Similar funds

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
PIMC
Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return
VIS
Vega Investment Solutions Paris, France $418M AUM
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return

Roman Butler Fullerton & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Roman Butler Fullerton & Co held 185 positions worth $157M, down 13% from $180M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Roman Butler Fullerton & Co withdrew a net $11.8M in Q3 2022, closing 16 positions and reducing 50 holdings. Its most notable exit was United Therapeutics, an estimated $1.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Roman Butler Fullerton & Co opened a new position in Regeneron Pharmaceuticals worth $1.35M.

  • Roman Butler Fullerton & Co's largest Q3 2022 buy was Regeneron Pharmaceuticals: 1,826 shares worth $1.35M.
  • Roman Butler Fullerton & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $888K increase.
  • Roman Butler Fullerton & Co's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $2.1M.
  • Roman Butler Fullerton & Co fully exited United Therapeutics in Q3 2022, selling an estimated $1.57M.
  • Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $157M portfolio in Q3 2022.
  • Roman Butler Fullerton & Co opened 10 new positions and closed 16 in Q3 2022.
  • Roman Butler Fullerton & Co's portfolio value fell 13% quarter-over-quarter to $157M.

Based on Roman Butler Fullerton & Co's 13F filing for Q3 2022, filed 17 Oct 2022.